Moreover, in a rat model of T2DM, adropin was found to reduce blood glucose levels, improve insulin sensitivity, ameliorate lipid profile, and suppress inflammatory marker (TNF-α, IL-6, and iNOS) expression [72]. This evidence concerns the gene INS and type 2 diabetes mellitus.